Literature DB >> 19325003

Signaling by hypoxia-inducible factors is critical for ovulation in mice.

Jaeyeon Kim1, Indrani C Bagchi, Milan K Bagchi.   

Abstract

The steroid hormone progesterone, acting via its nuclear receptor, is a major regulator of the process of ovulation. Female mice lacking progesterone receptor (PGR) exhibit an anovulatory phenotype due to failure in follicular rupture. To identify the PGR-regulated pathways that control ovulation, we analyzed global changes in gene expression in the ovaries of wild-type and Pgr-null mice subjected to gonadotropin-induced superovulation. Our analysis uncovered several genes whose expression was reduced in the Pgr-null ovaries compared with the wild-type ovaries immediately preceding ovulation. Interestingly, these genes included three hypoxia-inducible factors (HIFs): HIF-1 alpha, HIF-2 alpha, and HIF-1 beta. These transcription factors form alphabeta-heterodimers, which regulate the transcription of specific cellular genes, thereby mediating adaptive response of the tissue to low-oxygen levels. We observed that the expression of mRNAs and proteins corresponding to HIF-1 alpha, HIF-2 alpha, and HIF-1 beta was induced in a PGR-dependent manner, specifically in the granulosa cells of the preovulatory follicles. Inhibition of the HIF transcriptional activity by echinomycin, a small-molecule inhibitor that suppresses the binding of HIF alphabeta-heterodimers to target genes, blocked ovulation by preventing the rupture of the preovulatory follicles. Echinomycin specifically inhibited the expression of genes that are known regulators of ovulation, such as a disintegrin and metalloproteinase with thrombospondin-like motifs-1 and endothelin-2. Furthermore, echinomycin reduced the expression of vascular endothelial growth factor A, a key factor controlling vascularization/angiogenesis during ovulation. Collectively, these findings unveiled a novel ovarian role for the HIF transcription factors during the ovulatory period in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325003      PMCID: PMC2703551          DOI: 10.1210/en.2008-0948

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys.

Authors:  Timothy M Hazzard; Fuhua Xu; Richard L Stouffer
Journal:  Biol Reprod       Date:  2002-10       Impact factor: 4.285

Review 2.  Ovulation: new dimensions and new regulators of the inflammatory-like response.

Authors:  JoAnne S Richards; Darryl L Russell; Scott Ochsner; Lawrence L Espey
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

3.  Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells.

Authors:  J Gao; J Mazella; M Seppala; L Tseng
Journal:  Mol Cell Endocrinol       Date:  2001-05-15       Impact factor: 4.102

4.  A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation.

Authors:  Yong-Pil Cheon; Quanxi Li; Xueping Xu; Francesco J DeMayo; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2002-12

5.  ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function.

Authors:  T Shindo; H Kurihara; K Kuno; H Yokoyama; T Wada; Y Kurihara; T Imai; Y Wang; M Ogata; H Nishimatsu; N Moriyama; Y Oh-hashi; H Morita; T Ishikawa; R Nagai; Y Yazaki; K Matsushima
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  The aryl hydrocarbon receptor (AhR) and its nuclear translocator (Arnt) are dispensable for normal mammary gland development but are required for fertility.

Authors:  Fabienne Le Provost; Gregory Riedlinger; Sun Hee Yim; Jamie Benedict; Frank J Gonzalez; Jodi Flaws; Lothar Hennighausen
Journal:  Genesis       Date:  2002-03       Impact factor: 2.487

7.  Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.

Authors:  Yong Yuan; George Hilliard; Tsuneo Ferguson; David E Millhorn
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

8.  Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.

Authors:  Venkataraman Sriraman; Ursula Eichenlaub-Ritter; Jörg W Bartsch; Andrea Rittger; Sabine M Mulders; Joanne S Richards
Journal:  Biol Reprod       Date:  2008-02-20       Impact factor: 4.285

9.  Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice.

Authors:  Jaeyeon Kim; Marcey Sato; Quanxi Li; John P Lydon; Francesco J Demayo; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

10.  Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.

Authors:  Matthew J Grimshaw; Stuart Naylor; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2002-12       Impact factor: 6.261

View more
  42 in total

1.  In vivo imaging reveals an essential role of vasoconstriction in rupture of the ovarian follicle at ovulation.

Authors:  Fernando F Migone; Robert G Cowan; Rebecca M Williams; Kiersten J Gorse; Warren R Zipfel; Susan M Quirk
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-03       Impact factor: 11.205

2.  Dynamics of the transcriptome in the primate ovulatory follicle.

Authors:  Fuhua Xu; Richard L Stouffer; Jörg Müller; Jon D Hennebold; Jay W Wright; Alistair Bahar; Gabriele Leder; Michaele Peters; Melissa Thorne; Micaela Sims; Tim Wintermantel; Bernhard Lindenthal
Journal:  Mol Hum Reprod       Date:  2010-10-29       Impact factor: 4.025

3.  X-linked lymphocyte regulated gene 5c-like (Xlr5c-like) is a novel target of progesterone action in granulosa cells of periovulatory rat ovaries.

Authors:  Birendra Mishra; Ji Yeon Park; Kalin Wilson; Misung Jo
Journal:  Mol Cell Endocrinol       Date:  2015-05-21       Impact factor: 4.102

4.  Disruptions in follicle cell functions in the ovaries of rhesus monkeys during summer.

Authors:  Catherine A VandeVoort; Namdori R Mtango; Uros Midic; Keith E Latham
Journal:  Physiol Genomics       Date:  2015-01-13       Impact factor: 3.107

Review 5.  Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.

Authors:  Lowell Ling; Janet J Maguire; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 6.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

7.  The expression of CXCR4 is induced by the luteinizing hormone surge and mediated by progesterone receptors in human preovulatory granulosa cells.

Authors:  Yohan Choi; Ji Yeon Park; Kalin Wilson; Katherine L Rosewell; Mats Brännström; James W Akin; Thomas E Curry; Misung Jo
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

8.  Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary.

Authors:  Shanmugasundaram Nallasamy; Jaeyeon Kim; Regine Sitruk-Ware; Milan Bagchi; Indrani Bagchi
Journal:  Reprod Sci       Date:  2012-09-25       Impact factor: 3.060

Review 9.  Endocrine and local control of the primate corpus luteum.

Authors:  Richard L Stouffer; Cecily V Bishop; Randy L Bogan; Fuhua Xu; Jon D Hennebold
Journal:  Reprod Biol       Date:  2013-09-14       Impact factor: 2.376

Review 10.  Control of oocyte release by progesterone receptor-regulated gene expression.

Authors:  Rebecca L Robker; Lisa K Akison; Darryl L Russell
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.